Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

SRPT Sarepta Therapeutics PE ratio, current and historical analysis

The current PE ratio of SRPT can't be determined, as the TTM EPS of -$2.51 is negative. The last PE ratio of Sarepta Therapeutics, recorded in December 2024, was 49.23.

SRPT PE ratio history

How has SRPT's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Sarepta Therapeutics PE ratio by year

Year PE ratio PE change Price EPS
2024 49.23 N/A $121.59 $2.47
2023 N/A N/A $96.43 -$5.8
2022 N/A N/A $129.58 -$8.03
2021 N/A N/A $90.05 -$5.15
2020 N/A N/A $170.49 -$7.11
2019 N/A N/A $129.04 -$9.71
2018 N/A N/A $109.13 -$5.46
2017 N/A N/A $55.64 -$0.86
2016 N/A N/A $27.43 -$5.49
2015 N/A N/A $38.58 -$5.2
2014 N/A N/A $14.47 -$3.39
2013 N/A N/A $20.37 -$3.31
2012 N/A N/A $25.8 -$5.14
2011 N/A N/A $4.47 -$0.11
2010 N/A N/A $12.72 -$1.74

Sarepta Therapeutics PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Mar 2025 N/A N/A $63.82 -$2.51
Dec 2024 49.23 -38.51% $121.59 $2.47
Sep 2024 80.06 -62% $124.89 $1.56
Jun 2024 210.67 -33.28% $158 $0.75
Mar 2024 315.76 N/A $129.46 $0.41
Dec 2023 N/A N/A $96.43 -$5.8
Sep 2023 N/A N/A $121.22 -$7.83
Jun 2023 N/A N/A $114.52 -$10.31
Mar 2023 N/A N/A $137.83 -$12.69
Dec 2022 N/A N/A $129.58 -$8.03
Sep 2022 N/A N/A $110.54 -$8.22
Jun 2022 N/A N/A $74.96 -$5.88
Mar 2022 N/A N/A $78.12 -$4.25
Dec 2021 N/A N/A $90.05 -$5.15
Sep 2021 N/A N/A $92.48 -$6.13

SRPT Price vs fair value

How does SRPT's price compare to its estimated fair value based on its growth

SRPT average PE ratio chart

What is the average PE ratio of SRPT for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

SRPT PE vs peers

What is SRPT's PE ratio compared to its peers
Stock name PE ratio Market cap
NVAX Novavax Inc 2.36 $1.16B
PTCT Ptc Therapeutics Inc 6.76 $4.05B
GILD Gilead Sciences Inc 22.86 $135.61B
BCRX Biocryst Pharmaceuticals Inc N/A $2.31B
ALNY Alnylam Pharmaceuticals Inc N/A $39.81B
RNA Avidity Biosciences Inc N/A $4.12B
INSM INSMED Inc N/A $13.42B
SRPT Sarepta Therapeutics Inc N/A $3.89B

Frequently asked questions

What is Sarepta Therapeutics's PE ratio?

The current price to earnings ratio of SRPT can't be calculated, as its EPS of -$2.51 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.